These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26363974)

  • 61. [(-)-Epigallocatechin gallate, the main constituent of Japanese green tea, inhibits tumor promotion of okadaic acid].
    Yoshizawa S
    Fukuoka Igaku Zasshi; 1996 Oct; 87(10):215-21. PubMed ID: 8940799
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The analgesic effect of low dose focal irradiation in a mouse model of bone cancer is associated with spinal changes in neuro-mediators of nociception.
    Vit JP; Ohara PT; Tien DA; Fike JR; Eikmeier L; Beitz A; Wilcox GL; Jasmin L
    Pain; 2006 Jan; 120(1-2):188-201. PubMed ID: 16360279
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Continuous brachial plexus neural blockade in a child with intractable cancer pain.
    Cooper MG; Keneally JP; Kinchington D
    J Pain Symptom Manage; 1994 May; 9(4):277-81. PubMed ID: 8089545
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cellular and neurochemical remodeling of the spinal cord in bone cancer pain.
    Honoré P; Schwei J; Rogers SD; Salak-Johnson JL; Finke MP; Ramnaraine ML; Clohisy DR; Mantyh PW
    Prog Brain Res; 2000; 129():389-97. PubMed ID: 11098706
    [No Abstract]   [Full Text] [Related]  

  • 65. Pain management for bone metastases.
    LaCivita CL
    Am J Health Syst Pharm; 1996 Aug; 53(16):1907. PubMed ID: 8862202
    [No Abstract]   [Full Text] [Related]  

  • 66. Pharmacologic management of bone pain in the cancer patient.
    Payne R
    Clin J Pain; 1989; 5 Suppl 2():S43-9; discussion S49-50. PubMed ID: 2520440
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Substance P-saporin for bone cancer pain in dogs: can man's best friend solve the lost in translation problem in analgesic development?
    Hayashida K
    Anesthesiology; 2013 Nov; 119(5):999-1000. PubMed ID: 24195943
    [No Abstract]   [Full Text] [Related]  

  • 68. Assessing the analgesic efficacy of oral epigallocatechin-3-gallate on epidural catheter analgesia in patients after surgical stabilisation of multiple rib fractures: a prospective double-blind, placebo-controlled clinical trial.
    Zhang L; Liu W; You H; Chen Z; Xu L; He H
    Pharm Biol; 2020 Dec; 58(1):741-744. PubMed ID: 32749173
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antinociceptive effect of intrathecal injection of miR-9-5p modified mouse bone marrow mesenchymal stem cells on a mouse model of bone cancer pain.
    Zhu C; Wang K; Chen Z; Han Y; Chen H; Li Q; Liu Z; Qian L; Tang J; Shen H
    J Neuroinflammation; 2020 Mar; 17(1):85. PubMed ID: 32178691
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Therapeutic Potential of Flavonoids in Pain and Inflammation: Mechanisms of Action, Pre-Clinical and Clinical Data, and Pharmaceutical Development.
    Ferraz CR; Carvalho TT; Manchope MF; Artero NA; Rasquel-Oliveira FS; Fattori V; Casagrande R; Verri WA
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32050623
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antinociceptive effects of Ginsenoside Rb1 in a rat model of cancer-induced bone pain.
    Yao FD; Yang JQ; Huang YC; Luo MP; Yang WJ; Zhang B; Liu XJ
    Exp Ther Med; 2019 May; 17(5):3859-3866. PubMed ID: 30988771
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages.
    Staurengo-Ferrari L; Badaro-Garcia S; Hohmann MSN; Manchope MF; Zaninelli TH; Casagrande R; Verri WA
    Front Pharmacol; 2018; 9():1536. PubMed ID: 30687097
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectives.
    Bimonte S; Cascella M; Schiavone V; Mehrabi-Kermani F; Cuomo A
    Drug Des Devel Ther; 2017; 11():2737-2742. PubMed ID: 29066865
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Food-based natural products for cancer management: Is the whole greater than the sum of the parts?
    Hussain SS; Kumar AP; Ghosh R
    Semin Cancer Biol; 2016 Oct; 40-41():233-246. PubMed ID: 27397504
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain.
    Guedon JG; Longo G; Majuta LA; Thomspon ML; Fealk MN; Mantyh PW
    Pain; 2016 Jun; 157(6):1239-1247. PubMed ID: 27186713
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epigallocatechin-3-gallate attenuates bone cancer pain involving decreasing spinal Tumor Necrosis Factor-α expression in a mouse model.
    Li Q; Zhang X
    Int Immunopharmacol; 2015 Dec; 29(2):818-823. PubMed ID: 26363974
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.
    Ren BX; Gu XP; Zheng YG; Liu CL; Wang D; Sun YE; Ma ZL
    Anesthesiology; 2012 Jan; 116(1):122-32. PubMed ID: 22123524
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epigallocatechin-3-gallate treatment reduces thermal hyperalgesia after spinal cord injury by down-regulating RhoA expression in mice.
    Álvarez-Pérez B; Homs J; Bosch-Mola M; Puig T; Reina F; Verdú E; Boadas-Vaello P
    Eur J Pain; 2016 Mar; 20(3):341-52. PubMed ID: 25913854
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Involvement of the spinal NMDA receptor/PKCγ signaling pathway in the development of bone cancer pain.
    Xiaoping G; Xiaofang Z; Yaguo Z; Juan Z; Junhua W; Zhengliang M
    Brain Res; 2010 Jun; 1335():83-90. PubMed ID: 20362561
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea--a review.
    Fujiki H; Suganuma M; Okabe S; Sueoka E; Suga K; Imai K; Nakachi K
    Cancer Detect Prev; 2000; 24(1):91-9. PubMed ID: 10757128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.